State Street’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.25M | Buy |
790,136
+590,183
| +295% | +$2.75M | ﹤0.01% | 3179 |
|
|
2026
Q1 | $910K | Buy |
199,953
+26,700
| +15% | +$92.4K | ﹤0.01% | 3510 |
|
|
2025
Q4 | $348K | Buy |
173,253
+27,380
| +19% | +$55.6K | ﹤0.01% | 3775 |
|
|
2025
Q3 | $241K | Buy |
145,873
+75,400
| +107% | +$93.7K | ﹤0.01% | 3859 |
|
|
2025
Q2 | $66.4K | Hold |
70,473
| – | – | ﹤0.01% | 4045 |
|
|
2025
Q1 | $69.2K | Hold |
70,473
| – | – | ﹤0.01% | 4042 |
|
|
2024
Q4 | $83.9K | Hold |
70,473
| – | – | ﹤0.01% | 4027 |
|
|
2024
Q3 | $92.3K | Hold |
70,473
| – | – | ﹤0.01% | 3991 |
|
|
2024
Q2 | $108K | Hold |
70,473
| – | – | ﹤0.01% | 3995 |
|
|
2024
Q1 | $142K | Hold |
70,473
| – | – | ﹤0.01% | 3953 |
|
|
2023
Q4 | $212K | Buy |
70,473
+17,600
| +33% | +$52K | ﹤0.01% | 3888 |
|
|
2023
Q3 | $177K | Hold |
52,873
| – | – | ﹤0.01% | 3971 |
|
|
2023
Q2 | $229K | Sell |
52,873
-9,300
| -15% | -$44.2K | ﹤0.01% | 3958 |
|
|
2023
Q1 | $233K | Hold |
62,173
| – | – | ﹤0.01% | 4025 |
|
|
2022
Q4 | $219K | Hold |
62,173
| – | – | ﹤0.01% | 4060 |
|
|
2022
Q3 | $125K | Hold |
62,173
| – | – | ﹤0.01% | 4376 |
|
|
2022
Q2 | $119K | Hold |
62,173
| – | – | ﹤0.01% | 4446 |
|
|
2022
Q1 | $201K | Sell |
62,173
-14,000
| -18% | -$47.9K | ﹤0.01% | 4382 |
|
|
2021
Q4 | $284K | Buy |
76,173
+61,200
| +409% | +$245K | ﹤0.01% | 4202 |
|
|
2021
Q3 | $77K | Sell |
14,973
-39,600
| -73% | -$183K | ﹤0.01% | 4596 |
|
|
2021
Q2 | $288K | Buy |
+54,573
| New | +$271K | ﹤0.01% | 4072 |
|
|
2017
Q2 | – | Sell |
-84
| Closed | -$21K | – | 3742 |
|
|
2017
Q1 | $21K | Hold |
84
| – | – | ﹤0.01% | 3614 |
|
|
2016
Q4 | $6K | Hold |
84
| – | – | ﹤0.01% | 3656 |
|
|
2016
Q3 | $9K | Hold |
84
| – | – | ﹤0.01% | 3583 |
|
|
2016
Q2 | $10K | Hold |
84
| – | – | ﹤0.01% | 3703 |
|
|
2016
Q1 | $14K | Hold |
84
| – | – | ﹤0.01% | 3682 |
|
|
2015
Q4 | $15K | Hold |
84
| – | – | ﹤0.01% | 3668 |
|
|
2015
Q3 | $21K | Hold |
84
| – | – | ﹤0.01% | 3655 |
|
|
2015
Q2 | $24K | Hold |
84
| – | – | ﹤0.01% | 3664 |
|
|
2015
Q1 | $30K | Buy |
84
+17
| +25% | +$6.17K | ﹤0.01% | 3613 |
|
|
2014
Q4 | $23K | Sell |
67
-8
| -11% | -$2.76K | ﹤0.01% | 3640 |
|
|
2014
Q3 | $29K | Hold |
75
| – | – | ﹤0.01% | 3615 |
|
|
2014
Q2 | $32K | Hold |
75
| – | – | ﹤0.01% | 3581 |
|
|
2014
Q1 | $39K | Hold |
75
| – | – | ﹤0.01% | 3575 |
|
|
2013
Q4 | $18K | Hold |
75
| – | – | ﹤0.01% | 3601 |
|
|
2013
Q3 | $16K | Hold |
75
| – | – | ﹤0.01% | 3601 |
|
|
2013
Q2 | $16K | Buy |
+75
| New | +$12.9K | ﹤0.01% | 3534 |
|
Other funds holding IRD
CP
BCM
NCM
BCM
TECP
State Street's IRD Position: Q2 2026 in Review
State Street increased its Opus Genetics (IRD) stake by 295% in Q2 2026, buying an estimated $2.75M and bringing the position to 790,136 shares worth $3.25M. The position accounts for ﹤0.01% of the portfolio, ranked #3179.
State Street first reported a position in IRD in Q2 2013 and has held it in 37 quarters since. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.
- State Street held 790,136 shares of Opus Genetics worth $3.25M as of Q2 2026.
- State Street bought 590,183 Opus Genetics shares in Q2 2026, an estimated $2.75M.
- Opus Genetics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3179 holding.
- State Street first reported a position in Opus Genetics in Q2 2013 and has held it in 37 quarters since.
- 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.